Indefinite Delivery Contract SPE2DX15D9404
- Not listed
- The federal contract IDV award SPE2DX15D9647 is a single-award Indefinite Delivery Contract (IDC) issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at up to $4,999,999, enables DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables,...
- The federal contract IDV award SPE2DX16D9957 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded to the woman-owned small business DMS Pharmaceutical Group Inc. by the Defense Logistics Agency (DLA) under the SPE2DX program. The contract covers the delivery of a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide, including branded and generic prescription drugs, over-the-counter...
- The federal contract IDV award SPE2DX15D9145 is a single-award Indefinite Delivery Contract (IDC) granted by the Defense Logistics Agency (DLA) to the prime contractor, DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at up to $4,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the...
- The federal contract IDV award SPE2DX16D9908 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $4,999,999, was awarded by the Defense Logistics Agency (DLA) under the SPE2DX program and is valid through December 31, 2025. Under this IDC, DMS Pharmaceutical Group provides a comprehensive range of pharmaceutical products and medical supplies,...
- The federal contract IDV award SPE2DX15D9126 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $499,999,999 IDC, awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities...
- The federal contract IDV award SPE2DX16D9390 is a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.00, awarded by the Defense Logistics Agency (DLA) to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valid through November 2023, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical products, including branded and generic prescription drugs,...
- The federal contract IDV award SPE2DX15D6907 is an Indefinite Delivery Contract (IDC) between the Defense Logistics Agency (DLA) and the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $4,999,999.00 single-award IDC, awarded on March 23, 2017, covers the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support...
- The federal contract IDV award with ID SPE2DX15D9373 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $499,999,999 IDC, awarded by the Defense Logistics Agency (DLA) under the SPE2DB program, enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to support the medical supply needs of military health facilities worldwide. The IDC covers an...
- The federal contract IDV award SPE2DX15D9787 is a single-award Indefinite Delivery Contract (IDC) valued at up to $4,999,999.00, awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract's ultimate completion date is December 31, 2025, and it enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic prescription drugs,...
- The federal contract IDV award SPE2DX15D9749 is a single-award Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $499,999,999, was awarded by the Defense Logistics Agency (DLA) under the SPE2DB program and is valid through November 2026. The IDC enables the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items, including branded and generic...
The federal contract IDV award SPE2DX15D9404 is a single-award Indefinite Delivery Contract (IDC) valued at $4,999,999.00 and awarded to the prime contractor DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, awarded by the Defense Logistics Agency (DLA) under the SPE2DX program, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities and veterans' medical centers nationwide. The contract encompasses a diverse portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications. This IDC enables the DLA to issue firm fixed-price delivery orders for the required pharmaceutical items, positioning DMS Pharmaceutical Group as a crucial supplier in the federal pharmaceutical supply chain and providing direct distribution of prescription drugs and pharmacy services to Department of Defense healthcare sites. The contract period of performance is from the award date of March 10, 2015 through the ultimate completion date of December 31, 2025.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $0 | 3/30/15 |